The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 61 - 90 of 195 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Ilomedin 0,1 mg-ml infuusiokonsentraatti liuosta varten SPC 2021-10-27.docx
|
PL
|
Resepti
|
Ilomedin 0.1 mg-ml infuusiokonsentraatti SPC 2018-05-08
|
PL
|
Resepti
|
Iloprost Zentiva 10 mikrog - ml, 20 mikrog - ml sumutinliuos SPC 2023-04-24
|
|
|
European Medicines Agency's website: Ilumetri - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Iluvien 190 mikrog implantaatti silmän lasiaiseen, asetin SPC 2023-08-25
|
PL
|
Resepti
|
Imagopaque 200 mg I-ml injektioneste SPC 2003-02-26
|
PL
|
Resepti
|
Imagopaque 300 mg I-ml injektioneste SPC 2003-02-26
|
PL
|
Resepti
|
Imagopaque 350 mg I-ml injektioneste SPC 2003-02-26
|
|
|
European Medicines Agency's website: Imatinib Accord - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Imatinib Actavis - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Imatinib Krka d.d. 100 mg, 400 mg tabletti, kalvopäällysteinen SPC 2024-03-19
|
PL
|
Resepti
|
Imatinib Orion 100 mg, 400 mg kapseli, kova SPC 2022-11-28
|
PL
|
Resepti
|
Imatinib ratiopharm 100 mg, 400 mg tabletti, kalvopäällysteinen SPC 2024-04-03
|
PL
|
Resepti
|
Imatinib Sandoz 100 mg, 400 mg tabletti, kalvopäällysteinen SPC 2022-12-06
|
PL
|
Resepti
|
Imatinib Stada 100 mg 400 mg kapseli SPC 2023-10-18
|
PL
|
Resepti
|
Imatinib Stada 100 mg tabletti, kalvopäällysteinen SPC 2024-04-30
|
PL
|
Resepti
|
Imatinib STADA 600 mg tabletti, kalvopäällysteinen SPC 2022-05-30
|
|
|
European Medicines Agency's website: Imatinib Teva - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Imbruvica - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Imcivree - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Imdur 60 mg depottabletti SPC 2023-10-27
|
|
|
European Medicines Agency's website: Imfinzi - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Imigran 10 mg, 20 mg, nenäsumute SPC 2023-09-20
|
PL
|
Resepti
|
Imigran 12 mg-ml injektioneste SPC 2022-10-06
|
PL
|
Resepti
|
Imigran Radis 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-06-24
|
|
|
European Medicines Agency's website: IMJUDO - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Imlygic - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Imnovid (ent. Pomalidomide Celgene) - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti/itsehoito
|
Imocur 2 mg kapseli, kova SPC 2022-11-28
|
PL
|
Resepti
|
Imodium 2 mg kapseli, kova SPC 2023-01-10
|
|